Cite
An Examination of the Treatment Utility of the MMPI-2-RF: Prediction of Post-Treatment Depressive Symptoms and Increased Understanding of the Therapeutic Alliance in an Inpatient Mood Disorder Treatment.
MLA
Rodriguez, Taylor R., et al. “An Examination of the Treatment Utility of the MMPI-2-RF: Prediction of Post-Treatment Depressive Symptoms and Increased Understanding of the Therapeutic Alliance in an Inpatient Mood Disorder Treatment.” Journal of Personality Assessment, vol. 105, no. 5, Sept. 2023, pp. 667–78. EBSCOhost, https://doi.org/10.1080/00223891.2022.2137029.
APA
Rodriguez, T. R., Rufino, K. A., Patriquin, M. A., & Anestis, J. C. (2023). An Examination of the Treatment Utility of the MMPI-2-RF: Prediction of Post-Treatment Depressive Symptoms and Increased Understanding of the Therapeutic Alliance in an Inpatient Mood Disorder Treatment. Journal of Personality Assessment, 105(5), 667–678. https://doi.org/10.1080/00223891.2022.2137029
Chicago
Rodriguez, Taylor R., Katrina A. Rufino, Michelle A. Patriquin, and Joye C. Anestis. 2023. “An Examination of the Treatment Utility of the MMPI-2-RF: Prediction of Post-Treatment Depressive Symptoms and Increased Understanding of the Therapeutic Alliance in an Inpatient Mood Disorder Treatment.” Journal of Personality Assessment 105 (5): 667–78. doi:10.1080/00223891.2022.2137029.